Demyelination During Anti-Tumor Necrosis Factor α Therapy With Infliximab for Crohn's Disease

Carlton W. Thomas(Mayo Clinic in Arizona), William J. Sandborn(University of California, San Diego), Brian G. Weinshenker(Mayo Clinic in Arizona)
Inflammatory Bowel Diseases
December 15, 2003
Cited by 120


Related Papers